Voloridge Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-100,315
| Closed | -$6.54M | – | 1483 |
|
|
2022
Q2 | $6.54M | Sell |
100,315
-82,170
| -45% | -$5.36M | 0.03% | 578 |
|
|
2022
Q1 | $11.5M | Buy |
182,485
+119,056
| +188% | +$7.53M | 0.07% | 380 |
|
|
2021
Q4 | $3.36M | Sell |
63,429
-49,501
| -44% | -$2.63M | 0.02% | 873 |
|
|
2021
Q3 | $7.97M | Sell |
112,930
-94,090
| -45% | -$6.64M | 0.05% | 506 |
|
|
2021
Q2 | $13.8M | Buy |
207,020
+171,861
| +489% | +$11.5M | 0.1% | 284 |
|
|
2021
Q1 | $3.9M | Buy |
+35,159
| New | +$3.9M | 0.03% | 603 |
|
|
2020
Q4 | – | Sell |
-67,585
| Closed | -$5.9M | – | 1417 |
|
|
2020
Q3 | $5.9M | Sell |
67,585
-29,572
| -30% | -$2.58M | 0.05% | 404 |
|
|
2020
Q2 | $8.7M | Buy |
+97,157
| New | +$8.7M | 0.1% | 231 |
|
|
2020
Q1 | – | Sell |
-24,403
| Closed | -$2.8M | – | 1211 |
|
|
2019
Q4 | $2.8M | Buy |
24,403
+2,115
| +9% | +$243K | 0.05% | 410 |
|
|
2019
Q3 | $2.81M | Buy |
+22,288
| New | +$2.81M | 0.05% | 367 |
|
|
2019
Q2 | – | Sell |
-24,683
| Closed | -$2.16M | – | 878 |
|
|
2019
Q1 | $2.16M | Buy |
+24,683
| New | +$2.16M | 0.07% | 275 |
|
|
2018
Q3 | – | Sell |
-26,855
| Closed | -$2.41M | – | 365 |
|
|
2018
Q2 | $2.41M | Buy |
+26,855
| New | +$2.41M | 0.06% | 257 |
|
|
2018
Q1 | – | Sell |
-17,608
| Closed | -$1.02M | – | 551 |
|
|
2017
Q4 | $1.02M | Buy |
+17,608
| New | +$1.02M | 0.02% | 373 |
|